Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patrick Hilden
Early Fluid Overload Is a Serious Toxicity Associated With an Increased Risk of Non-Relapse Mortality After Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children With High-Risk Acute Leukemia Especially in the Setting of Single Units With Low Dose and/or a High Degree of HLA-Mismatch
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease and High Treatment Response
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Leveraging Technology and Education Improves Acute Graft-Versus-Host Disease Assessment and Data Capture
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) May Result in ATG Overexposure That Negatively Affects Outcomes
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes Between CD34 + Selected or Unmodified Hematopoietic Stem Cells Transplants
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Cytomegalovirus Reactivation Promotes CD8+ T Cell Subset Recovery After Unmodified Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Comparative Analysis of T CELL Depleted Matched vs Mismatched Unrelated DONOR Transplants in Patients With Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
1
2
›
